Patent · US Active

Theranostics platform and methods of use

US10161929B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2013
Grant dateDec 25, 2018
Priority date
Expiry dateApr 20, 2034

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2878
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Theranostics platforms for identifying drugs and nutraceuticals for treatment of rare disease are described. The platforms comprise (a) a cell-phenotype image-enhancing instrument; (b) a drug/nutraceutical library; and (c) a computer-implemented system for analyzing a response of an optically-visible rare-disease cell phenotype to a drug or nutraceutical from the drug/nutraceutical library.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.